Updated:24 May 2013 02:30:00 PM(IST)
Sensex19669.60
-4.73 -0.02%
Nifty5973.45
6.40 0.11%
Midcap6374.74
10.92 0.17%
Smallcap5982.23
7.78 0.13%
Biocon Ltd :
ISIN: INE376G01013 | NSE: BIOCON | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 532523 | Comments
| Price Information | |
| • Open | 278.00 |
| • High | 279.05 |
| • Low | 273.85 |
| • Previous Close | 275.60 |
| • Shares Traded | 7637 |
| • 52 Wk High Price | 321.50 |
| • 52 Wk High Date | - |
| • 52 Wk Low Price | 208.10 |
| • 52 Wk Low Date | - |
| • Face Value | 5.00 |
| Fundamentals | |
| • Market Capital (Rs.cr) | 5595.00 |
| • EPS (Rs.)(TTM) | 14.30 |
| • P/E Ratio(TTM) | 19.60 |
| • Book Value (Rs.) | 110.30 |
| • Price to Book Value | 2.54 |
| • Equity (Rs.cr.) | 100.00 |
| • Traded Value (Rs.lac) | 1161.29 |
| Corporate Actions | |
| Ex-Date | Purpose (Rs.) |
| 2012-07-05 | 100% Final Dividend (5) |
| Index Names | |
| • BSE-200 | |
| • BSE-500 | |
| • BSE HC | |
| • CNX Nifty Jr. | |
| Related Companies | ||
| Stock Name | Price | |
| CIPLA | 407.95 | |
| JBCHEPHARM | 82.65 | |
| JAYANTVITAMINS | 3.00 | - |
| MERIND | 200.00 | - |
| PIRHEALTH | 559.00 | |
| RANBAXY | 393.55 | |
| UNICHEMLAB | 170.50 | |
| ALEMBICLTD | 19.25 | |
| LYKALABS | 9.34 | |
| TTKHEALTH | 529.95 | |
| Share Tips for Biocon Ltd |
| Intraday trading calls : FII BOUGHT 665 (08:32AM, May 22 '13) |
| Market outlook : After flat open, marke (08:54AM, May 21 '13) |
| buy biocon future at cmp 289 : buy bio (02:17PM, Apr 25 '13) |
| Stock Option Tips --- BIOCON FUT HIGH (11:28AM, Apr 23 '13) |
| Indian Markets Outlook for the week:22 (12:29PM, Apr 20 '13) |
| Mutual funds holding in Biocon Ltd |
| Sahara Taxgain - Growth |
| HDFC Capital Builder Fund - Growth |
| Taurus Taxshield - Growth |
| Taurus Bonanza Fund - Growth |
| HDFC Balanced Fund - Growth |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| • Year End | Mar, 2013 | Mar, 2013 | Mar, 2013 |
| • Sales (Rs.cr) | 457.57 | 1837.48 | 1837.48 |
| • Net Profit (Rs.cr) | 49.25 | 286.70 | 286.70 |
| • Net Profit Var (%) | -21.00 | 12.00 | 12.00 |
| • EPS (Rs) | - | 14.30 | 14.30 |
| • P/E Ratio | - | 19.60 | 19.60 |
| • Operating Profit Margin | - | 22.10 | - |
| • CPS (Rs.) | - | - | 19.10 |
| • P/C Ratio | - | - | 14.70 |
| • Div% | - | - | 150.00 |
| Announcements | |
| 26-04-2013 | Biocon Recommends Final Dividend |
| 18-04-2011 | Biocon to announce financial results |
| 01-07-2011 | Biocon to announce Q1 results |
| 11-10-2011 | Biocon to announce Q2 results |
| 08-01-2013 | Biocon to announce Q3 results |
| 22-08-2011 | Clinigene International & Spaulding Clinical, US announces strategic partnership |
| 21-12-2011 | Clinigene International enters into collaborative clinical research services agreement with Pacific |
Gross Deliverables
Date
Del. Shares
Trd. Qty.
Del.(%)
Del. Value
Turnover
21-05-2013
4985
31906
15.62
1407016
8989.90
20-05-2013
158034
172185
91.78
44541883
49210.50
17-05-2013
6469
14038
46.08
1846253
4021.83
13-05-2013
6320
16762
37.70
1787296
4759.61
11-05-2013
781
1809
43.17
221882
513.59
Note:
- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, %
change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date &
not adjusted with corporate action
Comment(s) posted on Biocon Ltd
©2011 Appuonline.com